http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20100062136-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e06bbf2a93ce8414011cb5ba011faf8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 |
| filingDate | 2008-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aeebf734237195ce0cfb7b6d2cb0a217 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9f2aca20658a0c5e0b437ba8fe16016 |
| publicationDate | 2010-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20100062136-A |
| titleOfInvention | Econotonic-derived phloroglucinol derivatives with anti-HIB-1 inhibitory activity |
| abstract | The present invention relates to an Ecklonia cava-derived phloroglucinol derivative having an anti-HIV-1 inhibitory activity, an anti-HIV-1 inhibitory active pharmaceutical composition and a dietary supplement containing the same as an active ingredient, and the Ecklonia cava extract according to the present invention and The phloroglucinol derivative derived therefrom, 6,6'-bieckol, exhibits no cytotoxic effect compared to other tannins, inhibits HIV-1 induced cell fusion formation, inhibits p24 antigen production, and HIV-1. It has the effect of inhibiting reverse transcriptase activity. |
| priorityDate | 2008-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 88.